Nuveen Asset Management, LLC - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 59 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 2.54 and the average weighting 0.7%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$164,000
-33.6%
160,679
+0.8%
0.00%
Q4 2019$247,000
-15.4%
159,365
-1.0%
0.00%
Q3 2019$292,000
+10.6%
160,9340.0%0.00%
Q2 2019$264,000160,9340.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 41,909,219$21,793,00011.58%
Kore Private Wealth LLC 202,366$105,0000.02%
BARD ASSOCIATES INC 335,750$175,0000.02%
HighTower Advisors, LLC 5,284,688$2,738,0000.01%
GSA CAPITAL PARTNERS LLP 126,529$66,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 654,200$339,0000.01%
Virtu Financial LLC 57,076$30,0000.01%
WEDBUSH SECURITIES INC 81,500$42,0000.00%
MATRIX ASSET ADVISORS INC/NY 39,500$20,0000.00%
NEXPOINT ASSET MANAGEMENT, L.P. 33,933$18,0000.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders